title: Anticancer Teamwork: Cross-Presenting Dendritic Cells Collaborate with Therapeutic Monoclonal Antibodies.
abstract: Cross-presentation of tumor antigens represents a key pathway in antitumor immune responses that can be exploited to synergize not only with the already prominent "checkpoint blockade," but also with newer attempts to use T-cell stimulatory monoclonal antibodies in immunotherapy.
authors.affiliation: Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Canada.
authors.forename: Céline
authors.initials: C
authors.lastname: Robert-Tissot
authors.affiliation: Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Canada. Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Switzerland. doc@dspeiser.ch.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Speiser
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm